Increased volatility makes arbitrage trading vulnerable; if the stock market corrects, it could face a crash.
智通财经2026/10/08 08:06(1) Market analyst Jeremy Boulton stated that as market volatility rises and exchange rate fluctuations widen, currency carry trades are becoming increasingly vulnerable. (2) Adverse exchange rate movements may be sufficient to offset gains brought by favorable interest rate differentials, or even cause greater losses. (3) Some of the most popular carry trade currencies have already experienced substantial adverse price moves: since the outlook for a Federal Reserve rate hike in September became clear, the Mexican peso has fallen by as much as 9%, the South African rand has declined by over 5%, and the Hungarian forint has dropped by more than 7%. (4) Japan has taken measures to support the yen, leading to a slight appreciation, while a sharp sell-off in French bonds has hurt market confidence, dragging down the euro and boosting the Swiss franc. (5) This has further intensified the losses faced by carry trades that rely on stable market conditions. If the stock market undergoes further corrections, carry trades may face a collapse. (6) As investors take profits before year-end and amid the uncertainty of the US elections in November, equities and other risk assets may come under additional pressure.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ-Applied Digital shares surge as Q1 revenue quadruples
October 8 - ** Data center service provider Applied Digital (APLD.O) saw its stock rise 3.57% in pre-market trading to $24.66 ** The company’s Q1 revenue (link) surged more than fourfold to $341.9 millions, far surpassing analyst estimates of $133.8 millions ** Northland Capital Securities noted that APLD’s revenue and cash flow should increase significantly in the coming years as contracted data center capacity becomes operational and starts generating income ** Net loss attributable to common shareholders widened from $18.5 millions (7 cents/share) a year ago to $221 millions (76 cents/share) ** According to data compiled by London Stock Exchange Group (LSEG), the average rating from 17 analysts covering the stock is “Buy”, with a median target price of $70.00, representing an upside of about 194% from the current price ** Year-to-date, the stock is down about 2.9%, while the Nasdaq Index .IXIC is up 18.5% over the same period. (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automated translation may contain errors or lack necessary context, Reuters does not guarantee the accuracy of automated translation and provides it only as a convenience. Reuters assumes no liability for any damage or loss resulting from the use of automated translation.)

WTI crude oil rises above $91 per barrel, up 3.02% intraday
WTI crude oil rose above $91 per barrel for the first time since October 2, with a daily increase of 3.02%.
AstraZeneca (AZN.US) and Daiichi Sankyo (DSNKY.US) TROP2 ADC receives approval for new indication in China
According to information from Zhihu Finance APP, AstraZeneca (AZN.US) and Daiichi Sankyo (DSNKY.US) have announced that Datroway® (generic name: datopotamab deruxtecan for injection) has been approved by the National Medical Products Administration (NMPA) of China for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (TNBC) who are not suitable for PD-1/PD-L1 inhibitor therapies. Datopotamab deruxtecan is an antibody-drug conjugate (ADC) targeting TROP2, developed with proprietary technology by Daiichi Sankyo, and jointly developed and commercialized by AstraZeneca and Daiichi Sankyo.
Abu Dhabi National Oil Company invites bids for crude oil cargo shipments
Trader: Abu Dhabi National Oil Company issued a tender this week to sell crude oil for December loading or January delivery.